Poster: AACR (American Association for Cancer Research), April 5-10, 2024, San Diego CA
Poster
April 8, 2024
A systemically delivered, clinically-ready, attenuated Salmonella Typhimurium strain ACTM-838 alters the tumor microenvironment and provides durable anti-tumor activity in vivo